These cells have not only been shown to be equally effective as heterogeneous MSC populations in the treatment of pneumonia [85,86] but CD362 was even identified as a major regulator of therapeutic action regarding treatment of sepsis [87]. This evidence concerns the gene SDC2 and susceptibility to pneumonia measurement.